Pharmaceutical Giant Bayer's Shares Plunge 7% as Washington Supreme Court Reopens PCB Case

Pharmaceutical Giant Bayer's Shares Plunge 7% as Washington Supreme Court Reopens PCB Case

Bayer AG's shares dropped 7% after the Washington Supreme Court's review of claims linked to PCB exposure from its Monsanto unit. The ongoing legal battles over health hazards from Monsanto products, including Roundup, continue to impact Bayer's financial health and investor confidence.

Read More

Did you find this insightful?